Search by Drug Name or NDC

    NDC 24208-0537-08 LUMIFY Redness Reliever Eye Drops 0.25 mg/mL Details

    LUMIFY Redness Reliever Eye Drops 0.25 mg/mL

    LUMIFY Redness Reliever Eye Drops is a OPHTHALMIC SOLUTION/ DROPS in the HUMAN OTC DRUG category. It is labeled and distributed by Bausch & Lomb Incorporated. The primary component is BRIMONIDINE TARTRATE.

    Product Information

    NDC 24208-0537
    Product ID 24208-537_31470602-4f2f-4341-a0b3-ddf14278df7e
    Associated GPIs 86602020102002
    GCN Sequence Number 078056
    GCN Sequence Number Description brimonidine tartrate DROPS 0.025 % OPHTHALMIC
    HIC3 Q6D
    HIC3 Description EYE VASOCONSTRICTORS (OTC ONLY)
    GCN 44289
    HICL Sequence Number 011786
    HICL Sequence Number Description BRIMONIDINE TARTRATE
    Brand/Generic Brand
    Proprietary Name LUMIFY Redness Reliever Eye Drops
    Proprietary Name Suffix n/a
    Non-Proprietary Name BRIMONIDINE TARTRATE
    Product Type HUMAN OTC DRUG
    Dosage Form SOLUTION/ DROPS
    Route OPHTHALMIC
    Active Ingredient Strength 0.25
    Active Ingredient Units mg/mL
    Substance Name BRIMONIDINE TARTRATE
    Labeler Name Bausch & Lomb Incorporated
    Pharmaceutical Class Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA208144
    Listing Certified Through 2024-12-31

    Package

    NDC 24208-0537-08 (24208053708)

    NDC Package Code 24208-537-08
    Billing NDC 24208053708
    Package 1 BOTTLE, DROPPER in 1 CARTON (24208-537-08) / 2.5 mL in 1 BOTTLE, DROPPER
    Marketing Start Date 2017-12-22
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 2.9888
    Pricing Unit ML
    Effective Date 2022-03-23
    NDC Description LUMIFY 0.025% EYE DROP
    Pharmacy Type Indicator C/I
    OTC Y
    Explanation Code 4, 5
    Classification for Rate Setting B
    As of Date 2022-11-23
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis